glp-1 eli lilly Novo, weight-loss drugs should be first option obesity treatments, European doctors say FDA approval for Zepbound (tirzepatide)

While weight loss is achievable, weight maintenance remains a lifetime challenge ( A new generation of anti-obesity medications (AOMs) has revolutionized the way obesity is treated, enabling most patients to lose 10-20% of their body weight

Understanding Histamine, MTHFR and Mast Cell Activation Syndrome March 20, 2026 If you experience fatigue, digestive issues or reactions to certain foods, you may also have read about histamine intolerance or mast cell activation syndrome (MCAS)

Formulated to gently cleanse, brighten, and restore your skin's healthy glow

The most significant aspect of our research is the observation of a remarkable increase in the redox activity of A

Priyanka Shah , (B.Pharm) Side effects are unwanted symptoms caused by medicines